Close

CAR-T Cytokine Release Test Kits

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Effective monitoring of cytokine release during CAR-T therapy is critical for patient safety and treatment optimization. This is where CAR-T Cytokine Release Test Kits come into play. Creative Biolabs offers state-of-the-art CAR-T Cytokine Release Test Kits designed to evaluate and mitigate the risks associated with CRS. These kits provide valuable insights into the patient's immune response and the level of cytokine release, enabling timely intervention when necessary.

With our CAR-T Cytokine Release Test Kits, You Can Expect:

  • High-Sensitivity Cytokine Assays

Our kits include high-sensitivity assays for the detection of cytokines such as interleukin-6 (IL-6), interferon-gamma (IFN-γ), and tumor necrosis factor-alpha (TNF-α). These cytokines play a pivotal role in the development of CRS and are critical indicators of its severity.

  • Multiplexed Analysis

Creative Biolabs' CAR-T Cytokine Release Test Kits utilize multiplexed analysis techniques, allowing for the simultaneous measurement of multiple cytokines in a single sample. This comprehensive approach provides a more accurate assessment of the cytokine profile, enabling better clinical decision-making.

  • Real-time Monitoring

Our kits offer real-time monitoring capabilities, allowing for continuous assessment of cytokine levels during and after CAR-T cell infusion. This dynamic monitoring is crucial for timely intervention and the prevention of severe CRS-related complications.

Our CAR-T Cytokine Release Test Kits

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.